These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
898 related articles for article (PubMed ID: 32831169)
1. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini. Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P Elife; 2020 Aug; 9():. PubMed ID: 32831169 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Immediate Initiation of Antiretroviral Therapy on Patients' Healthcare Expenditures: A Stepped-Wedge Randomized Trial in Eswatini. Steinert JI; Khan S; Mafara E; Wong C; Mlambo K; Hettema A; Walsh FJ; Lejeune C; Mazibuko S; Okello V; Ogbuoji O; De Neve JW; Vollmer S; Bärnighausen T; Geldsetzer P AIDS Behav; 2021 Oct; 25(10):3194-3205. PubMed ID: 33834318 [TBL] [Abstract][Full Text] [Related]
3. Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector: the MaxART stepped-wedge randomized controlled trial. Khan S; Spiegelman D; Walsh F; Mazibuko S; Pasipamire M; Chai B; Reis R; Mlambo K; Delva W; Khumalo G; Zwane M; Fleming Y; Mafara E; Hettema A; Lejeune C; Chao A; Bärnighausen T; Okello V J Int AIDS Soc; 2020 Sep; 23(9):e25610. PubMed ID: 32949103 [TBL] [Abstract][Full Text] [Related]
4. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. Jakubowski A; Snyman K; Kwarisiima D; Sang N; Burger R; Balzer L; Clark T; Chamie G; Shade S; Cohen C; Bukusi E; Charlebois E; Kamya M; Petersen M; Havlir D; Thirumurthy H PLoS One; 2018; 13(6):e0198912. PubMed ID: 29944678 [TBL] [Abstract][Full Text] [Related]
5. Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction. Ogbuoji O; Geldsetzer P; Wong C; Khan S; Mafara E; Lejeune C; Walsh F; Okello V; Bärnighausen T AIDS; 2020 Feb; 34(2):267-276. PubMed ID: 31634194 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini. Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613 [TBL] [Abstract][Full Text] [Related]
8. "Is it making any difference?" A qualitative study examining the treatment-taking experiences of asymptomatic people living with HIV in the context of Treat-all in Eswatini. Horter S; Wringe A; Thabede Z; Dlamini V; Kerschberger B; Pasipamire M; Lukhele N; Rusch B; Seeley J J Int AIDS Soc; 2019 Jan; 22(1):e25220. PubMed ID: 30697970 [TBL] [Abstract][Full Text] [Related]
9. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial. Walsh FJ; Bärnighausen T; Delva W; Fleming Y; Khumalo G; Lejeune CL; Mazibuko S; Mlambo CK; Reis R; Spiegelman D; Zwane M; Okello V Trials; 2017 Aug; 18(1):383. PubMed ID: 28821264 [TBL] [Abstract][Full Text] [Related]
10. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Amanyire G; Semitala FC; Namusobya J; Katuramu R; Kampiire L; Wallenta J; Charlebois E; Camlin C; Kahn J; Chang W; Glidden D; Kamya M; Havlir D; Geng E Lancet HIV; 2016 Nov; 3(11):e539-e548. PubMed ID: 27658873 [TBL] [Abstract][Full Text] [Related]
11. Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study. Barnabas RV; van Heerden A; McConnell M; Szpiro AA; Krows ML; Schaafsma TT; Ngubane T; Nxele RB; Joseph P; Baeten JM; Celum CL; van Rooyen H J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25519. PubMed ID: 32589342 [TBL] [Abstract][Full Text] [Related]
13. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania. Geldsetzer P; Francis JM; Sando D; Asmus G; Lema IA; Mboggo E; Koda H; Lwezaula S; Ambikapathi R; Fawzi W; Ulenga N; Bärnighausen T PLoS Med; 2018 Sep; 15(9):e1002659. PubMed ID: 30231024 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys. Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559 [TBL] [Abstract][Full Text] [Related]
15. Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial. Jakubowski A; Kabami J; Balzer LB; Ayieko J; Charlebois ED; Owaraganise A; Marquez C; Clark TD; Black D; Shade SB; Chamie G; Cohen CR; Bukusi EA; Kamya MR; Petersen M; Havlir DV; Thirumurthy H Lancet Glob Health; 2022 Jan; 10(1):e96-e104. PubMed ID: 34919862 [TBL] [Abstract][Full Text] [Related]
16. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694 [TBL] [Abstract][Full Text] [Related]
17. HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort study. Kerschberger B; Schomaker M; Jobanputra K; Kabore SM; Teck R; Mabhena E; Mthethwa-Hleza S; Rusch B; Ciglenecki I; Boulle A J Int AIDS Soc; 2020 Mar; 23(3):e25458. PubMed ID: 32128964 [TBL] [Abstract][Full Text] [Related]
18. Mortality under early access to antiretroviral therapy vs. Eswatini's national standard of care: the MaxART clustered randomized stepped-wedge trial. Chao A; Spiegelman D; Khan S; Walsh F; Mazibuko S; Pasipamire M; Chai B; Reis R; Mlambo K; Delva W; Khumalo G; Zwane M; Fleming Y; Mafara E; Hettema A; Lejeune C; Bärnighausen T; Okello V HIV Med; 2020 Aug; 21(7):429-440. PubMed ID: 32458567 [TBL] [Abstract][Full Text] [Related]
19. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART. Ujeneza EL; Ndifon W; Sawry S; Fatti G; Riou J; Davies MA; Nieuwoudt M; Elife; 2021 Jan; 10():. PubMed ID: 33443013 [TBL] [Abstract][Full Text] [Related]